Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-23 4:15 pm Purchase |
2023-02-16 | 13D | Spruce Biosciences, Inc. SPRB |
Carlyle Group Inc. CG |
3,734,518 9.200% |
1,932,000 (+107.18%) |
Filing History |
| 2023-02-21 4:28 pm Purchase |
2023-02-16 | 13D | Spruce Biosciences, Inc. SPRB |
Novo Holdings A/S | 8,378,336 19.900% |
3,864,000 (+85.59%) |
Filing History |
| 2023-02-14 2:56 pm Unchanged |
2022-12-31 | 13G | Spruce Biosciences, Inc. SPRB |
Rock Springs Capital Management LP | 1,622,689 6.890% |
0 (Unchanged) |
Filing History |
| 2023-02-14 08:02 am Purchase |
2022-12-31 | 13G | Spruce Biosciences, Inc. SPRB |
Citadel Advisors LLC | 1,747,391 7.400% |
12,322 (+0.71%) |
Filing History |
| 2023-02-13 4:16 pm Purchase |
2023-02-08 | 13D | Spruce Biosciences, Inc. SPRB |
HealthCap VIII L.P. | 3,685,621 8.900% |
1,652,000 (+81.23%) |
Filing History |
| 2022-09-30 4:54 pm Unchanged |
2022-09-27 | 13D | Spruce Biosciences, Inc. SPRB |
Novo Holdings A/S | 4,514,336 19.200% |
0 (Unchanged) |
Filing History |
| 2022-08-11 4:50 pm Purchase |
2022-08-01 | 13D | Spruce Biosciences, Inc. SPRB |
Carlyle Group Inc. CG |
1,802,518 7.700% |
1,802,518 (New Position) |
Filing History |
| 2022-02-14 6:24 pm Sale |
2021-12-31 | 13G | Spruce Biosciences, Inc. SPRB |
Rock Springs Capital Management LP | 1,622,689 6.920% |
-8,311 (-0.51%) |
Filing History |
| 2022-02-14 06:12 am Purchase |
2021-12-31 | 13G | Spruce Biosciences, Inc. SPRB |
Citadel Advisors LLC | 1,735,069 7.400% |
33,282 (+1.96%) |
Filing History |
| 2022-02-11 4:21 pm Sale |
2021-12-31 | 13G | Spruce Biosciences, Inc. SPRB |
Flynn James E | 0 0.000% |
-1,419,651 (Position Closed) |
Filing History |
| 2022-02-09 10:01 am Sale |
2022-02-08 | 13G | Spruce Biosciences, Inc. SPRB |
FMR CORP | 114,500 0.488% |
-1,079,773 (-90.41%) |
Filing History |
| 2021-11-22 4:08 pm Unchanged |
2021-11-08 | 13D | Spruce Biosciences, Inc. SPRB |
Novo Holdings A/S | 4,514,336 19.200% |
0 (Unchanged) |
Filing History |
| 2021-05-21 4:32 pm Sale |
2021-05-19 | 13D | Spruce Biosciences, Inc. SPRB |
Novo Holdings A/S | 4,514,336 19.400% |
-475,000 (-9.52%) |
Filing History |
| 2021-05-17 4:49 pm Purchase |
2021-05-05 | 13G | Spruce Biosciences, Inc. SPRB |
Flynn James E | 1,419,651 6.090% |
1,419,651 (New Position) |
Filing History |
| 2021-02-16 4:32 pm Sale |
2020-12-31 | 13G | Spruce Biosciences, Inc. SPRB |
Rock Springs Capital Management LP | 1,631,000 7.030% |
-77,673 (-4.55%) |
Filing History |
| 2021-02-16 4:30 pm Unchanged |
2020-12-31 | 13G | Spruce Biosciences, Inc. SPRB |
Citadel Advisors LLC | 1,701,787 7.300% |
0 (Unchanged) |
Filing History |
| 2021-02-12 4:17 pm Purchase |
2020-12-31 | 13G | Spruce Biosciences, Inc. SPRB |
ELMS STEVE | 1,205,511 5.180% |
1,205,511 (New Position) |
Filing History |
| 2021-02-12 1:46 pm Purchase |
2020-12-31 | 13G | Spruce Biosciences, Inc. SPRB |
Omega Fund VI, L.P. | 2,161,023 9.300% |
2,161,023 (New Position) |
Filing History |
| 2021-02-08 10:33 am Purchase |
2021-02-05 | 13G | Spruce Biosciences, Inc. SPRB |
FMR CORP | 1,194,273 5.144% |
1,194,273 (New Position) |
Filing History |
| 2020-12-18 4:11 pm Purchase |
2020-10-14 | 13D | Spruce Biosciences, Inc. SPRB |
HealthCap VIII L.P. | 2,033,621 8.800% |
2,033,621 (New Position) |
Filing History |